FlexMend by Futurebiotics — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

4 Tablet(s) Serving Size

22 Servings

Other Combinations Product Type

25% Evidence Coverage

Supplement Facts — Evidence Check

Glucosamine Hydrochloride

1500 mg

📊 Market median: 1000.0mg (1115 products) 📚 22 studies (Tier A: 0, B: 9)

This product: 1500mg

OptiMSM

1500 mg

Proprietary Flex Support Compound

360 mg

Futurebiotics BioAccelerators

23 mg

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Stearic Acid Magnesium Stearate Silicon Dioxide Ginger Oil Hydroxypropyl Methylcellulose Riboflavin Polyethylene Glycol Titanium Dioxide

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (89% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions: As a dietary supplement for adults, take 4 tablets daily, preferably with meals.

⚠️ Warnings & Precautions

Do not use if you are pregnant or nursing.

Keep out of reach of children.

🧪 Formulation Notes

This 100% vegetarian product has an aromatic botanical essence added, along with natural whole plant co-factors including Turmeric root.

100% Satisfaction Guaranteed

Vegetarian glucosamine with MSM Clinically studied nutrients for normal joint function

Vegetarian glucosamine with MSM

Additional Information

Protect from light.

FlexMend - taking inspiration from Nature.

Best if used by date shown on bottle.

FutureBiotics Health. Nature. Life.

Product Details

UPC / SKU 0 49479 02504 6

DSLD Entry Date 2024-10-24

Product Type Other Combinations

Form Tablet or Pill

Brand Futurebiotics

DSLD ID 319853

Data Updated 2026-04-11

Research Evidence

39 Research Sources

50 Avg Quality Score

20 Rct

9 Meta Analysis

4 Clinical Trial

3 Systematic Review

1 Regulatory Source

1 Openfda Safety

B Interventions for the management of temporomandibular joint osteoarthritis

Systematic Review The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

B Glucosamine therapy for treating osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2005

PubMed Cochrane

B Chondroitin for osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis

Meta Analysis Archives of orthopaedic and trauma surgery 2023

PubMed DOI

B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Rct The New England journal of medicine 2006

PubMed

B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review

Systematic Review International journal of molecular sciences 2023

PubMed DOI

B Scientific Opinion on glucosamine and joint health

Regulatory Source EFSA Journal 2009

DOI

B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

Meta Analysis Computational and mathematical methods in medicine 2022

PubMed DOI

B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Rct Annals of the rheumatic diseases 2016

PubMed DOI

B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Meta Analysis Journal of orthopaedic surgery and research 2018

PubMed DOI

View all evidence for Glucosamine →